With Myeloma Drug Proving Merit in Phase I, AbbVie Scoops Up TeneoOne
The decision to exercise the option was based on an interim analysis of the ongoing Phase I trial of TNB-383B.
The Home of the Life Sciences Industry
Explore Latest News
COVID-19 Origin Story Plot Thickens as Researcher Unearths Deleted Early Virus Sequences
Last summer, claims that the deadly SARS-CoV-2 virus emerged from a virology lab in Wuhan were generally dismissed by the scientific community as right-wing conspiracy theories. A year later, the theory isn’t sounding so far-fetched.
- Eli Lilly Guns for Alzheimer's Drug Approval with FDA's Breakthrough Therapy Designation
- EQRX and Exscientia Team Up to Bring Low-Cost Immunotherapies to the World
- Pfizer and AZ Prove Their COVID-19 Vaccines Can Keep Up with Delta and Kappa Variants
- FDA Tackles Busy Week with Drug Approvals, INDs and NDAs
- Global Roundup: uniQure Snaps Up Corlieve, Avacta Group's Deal and More
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.